MedPath

Low-dose Computer Tomography in Follow-up of Soft Tissue Sarcomas

Not Applicable
Completed
Conditions
Sarcoma,Soft Tissue
Interventions
Diagnostic Test: ultra-low-dose computed tomography
Registration Number
NCT05813808
Lead Sponsor
Helsinki University Central Hospital
Brief Summary

The goal of this interventional study is to compare sensitivity of regular chest x-ray to ultra-low-dose computed tomography to find pulmonary relapse in follow-up of soft tissue sarcoma. The main question\[s\] it aims to answer are:

* Is ultra-low-dose computed tomography more sensitive than regular chest x-ray to find pulmonary relapse?

* Does ultra-low-dose computed tomography detect the most fast-growing pulmonary metastases earlier than regular chest x-ray?

Participants will have seven ultra-low-dose computed tomography imagings in addition to simultaneous routine protocol of chest x-rays. Participants therefore work as their own controls.

Detailed Description

After primary treatment with curative intent for soft tissue sarcoma, patients fulfilling the inclusion criteria and giving informed consent are enrolled. In study protocol patients have their regular chest x-ray once in two months plus ultra-low-dose computed tomography imaging is repeated seven times during the first two years of follow-up. After two years patients without detectable metastases continue in regular follow-up program. The aims of this prospective comparative study are to investigate whether ultra-low-dose computed tomography is more accurate than chest x-ray in soft tissue sarcoma and especially whether the most fast-growing pulmonary metastases could be detected earlier.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • primary high grade soft tissue sarcoma with no metastases at diagnoses or during treatment and treatment with curative intent.
Exclusion Criteria
  • metastases at diagnoses or during treatment

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
chest x-ray and ultra-low-dose computed tomographyultra-low-dose computed tomography-
Primary Outcome Measures
NameTimeMethod
Number of patients with pulmonary relapse detected by ultra-low-dose CT performed according to a pre-defined schedule2 years
Number of patients with pulmonary relapse detected by chest x-ray performed according to a pre-defined schedule2 years
Number of patients with pulmonary relapse by symptoms2 years

Pulmonary relapse based on patient-reported symptoms leading to positive finding in x-ray and or conventional chest CT between two control imaging rounds.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Helsinki University Hospital Comprehensive Cancer Center

🇫🇮

Helsinki, Valitse Alue, Osavaltio Tai Maakunta, Finland

© Copyright 2025. All Rights Reserved by MedPath